New Diamond-Tipped catheter takes on heart rhythm disorder
NCT ID NCT06028919
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This trial tested a new ablation catheter (DiamondTemp) against the current standard (Tacticath/Tactiflex) for treating ventricular tachycardia (VT), a life-threatening fast heart rhythm. 61 adults with VT who needed ablation took part. The goal was to see if the new catheter is as safe and effective at reducing VT episodes over 12 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
DiamondTemp ablation catheter (device) vs Tacticath/Tactiflex ablation catheter (device)
What this could lead to
If the DiamondTemp catheter works as well as the standard one, it could offer doctors another safe and effective tool to treat VT and reduce the need for painful shocks from defibrillators.
What could go wrong
This is a small, completed trial with only 61 people, so results may not apply to everyone. The new catheter might not be as effective or safe as the current standard, and any ablation procedure carries risks like bleeding or heart damage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENTRICULAR TACHYCARDIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital Coventry and Warwickshire NHS Trust
Coventry, West Midlands, CV22DX, United Kingdom
-
University Hospitals Sussex NHS Foundation Trust
Brighton, BN2 1ES, United Kingdom